Metacrine-Logo-R Transparent.png.png
Metacrine to Present New Preclinical Data on MET642 in Inflammatory Bowel Disease at Digestive Disease Week 2021 Virtual Meeting
May 19, 2021 08:05 ET | Metacrine, Inc.
SAN DIEGO, May 19, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal...
Logo.png
Interpace Diagnostics Reports Second Quarter 2019 Financial Results and Provides Business Update
August 13, 2019 08:15 ET | Interpace Diagnostics Group, Inc.
Second Quarter Revenue Grew 14% Over the Prior Year and 19% Year to Date Over the Prior Year Acquired Growing BioPharma Services Business Net Revenue Guidance Increased Conference Call and...
IDXG Logo.jpg
Interpace Diagnostics BarreGEN® Data to be Presented at Digestive Disease Week
May 09, 2019 06:55 ET | Interpace Diagnostics Group, Inc.
Company to Host Fellowship and Key Opinion Leader Programs PARSIPPANY, NJ, May 09, 2019 (GLOBE NEWSWIRE) --  Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that data from an...
breathtec.jpg
Nash Pharmaceuticals to Present Data on Its Inflammatory Bowel Disease Research Program at The Digestive Disease Week Annual Conference
February 13, 2019 07:00 ET | Breathtec Biomedical Inc.
VANCOUVER, British Columbia, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI)...
PENTAX Medical Launches the SCOPEPILOT True 3D Endoscope Navigation System in Canada
March 03, 2017 07:30 ET | PENTAX Medical
MISSISSAUGA, Ontario, March 03, 2017 (GLOBE NEWSWIRE) -- PENTAX Medical, an industry leader in endoscopy imaging devices, has introduced SCOPEPILOT to the Canadian market and is showcasing this new...